Anthem Biosciences shares list at 27% premium over IPO price on NSE; should you buy, sell or hold?
Anthem Biosciences shares listed on the stock exchanges on Monday with a premium of about 27 percent over it's initial public offer (IPO) price. The Rs 3,395-crore public offer was priced in the band of Rs 540-570 per share, and received strong investor interest with about 64 times subscription during the offer period from July 14 to 16.
On the BSE, the shares were listed at Rs 723.10 apiece, a premium of 26.86 percent. The total market capitalization post listing of the shares of the company stood at Rs 40,610.02 crore. The company had earlier raised Rs 1,016-crore from anchor investors.fdfdfdfdfdfdfdfd
What is Digital Marketing:
Heading:
Sub Heading
suydgsudgs

Comments
Post a Comment